Robert W. Baird Lowers Henry Schein Inc. (HSIC) to Neutral
Robert W. Baird cut shares of Henry Schein Inc. (NASDAQ:HSIC) from an outperform rating to a neutral rating in a research note released on Friday. They currently have $164.00 price objective on the stock, down from their previous price objective of $176.00.
Several other research analysts have also recently issued reports on HSIC. Zacks Investment Research upgraded shares of Henry Schein from a sell rating to a hold rating in a report on Wednesday, October 5th. Bank of America Corp. began coverage on shares of Henry Schein in a report on Monday, September 12th. They issued a buy rating and a $185.00 target price on the stock. Finally, Goldman Sachs Group Inc. upgraded shares of Henry Schein from a neutral rating to a buy rating and set a $185.00 target price on the stock in a report on Tuesday, October 11th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and five have issued a buy rating to the stock. The stock presently has an average rating of Hold and an average price target of $159.50.
Shares of Henry Schein (NASDAQ:HSIC) opened at 153.35 on Friday. Henry Schein has a 52 week low of $142.64 and a 52 week high of $183.00. The firm’s 50-day moving average is $161.57 and its 200-day moving average is $169.75. The company has a market cap of $12.54 billion, a price-to-earnings ratio of 25.98 and a beta of 1.05.
Henry Schein (NASDAQ:HSIC) last issued its earnings results on Thursday, August 4th. The company reported $1.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.63 by $0.01. Henry Schein had a net margin of 4.42% and a return on equity of 17.84%. The firm had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.85 billion. During the same quarter last year, the business earned $1.46 earnings per share. The business’s revenue was up 9.3% on a year-over-year basis. Equities research analysts predict that Henry Schein will post $6.57 earnings per share for the current year.
In other Henry Schein news, Director Paul Brons sold 3,381 shares of the firm’s stock in a transaction on Monday, August 29th. The stock was sold at an average price of $164.03, for a total transaction of $554,585.43. Following the completion of the transaction, the director now owns 13,715 shares of the company’s stock, valued at $2,249,671.45. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.27% of the company’s stock.
Institutional investors have recently made changes to their positions in the stock. Zurich Insurance Group Ltd FI purchased a new position in shares of Henry Schein during the first quarter valued at approximately $3,204,000. National Pension Service raised its position in shares of Henry Schein by 4.4% in the first quarter. National Pension Service now owns 56,059 shares of the company’s stock valued at $9,677,000 after buying an additional 2,383 shares in the last quarter. AMP Capital Investors Ltd raised its position in shares of Henry Schein by 1.7% in the first quarter. AMP Capital Investors Ltd now owns 23,958 shares of the company’s stock valued at $4,141,000 after buying an additional 400 shares in the last quarter. Citizens Financial Group Inc RI raised its position in shares of Henry Schein by 1.0% in the first quarter. Citizens Financial Group Inc RI now owns 46,377 shares of the company’s stock valued at $8,006,000 after buying an additional 452 shares in the last quarter. Finally, Prudential PLC raised its position in shares of Henry Schein by 57.5% in the first quarter. Prudential PLC now owns 6,300 shares of the company’s stock valued at $1,088,000 after buying an additional 2,300 shares in the last quarter. 92.03% of the stock is owned by institutional investors and hedge funds.
Henry Schein Company Profile
Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.